Summary
A total of 25 patients with the diagnosis of interstitial cystitis (IC) were involved in this study. All patients had been previously diagnosed with interstitial cystitis and had received treatment with single intravesical agents. Patients were divided into two groups according to their bladder capacity. The bladder capacity was >350 ml in group I patients and <350 ml in group II patients. For our study, dimethylsulfoxide (DMSO), methylprednisolone, and heparin sulfate were given every week for a total of 6 weeks. When symptoms recurred, supportive oral pharmacotherapy consisting of anticholinergics and/or tricyclic antidepressants was given. Under anesthesia, patients in group I showed a 99% increase in their bladder capacity; whereas those in group II showed an increase of only 19%. Cystoscopically, Hunner's ulcers were present in 60% of the group II patients but were seen in only 5% of the group I patients. Histopathological examination showed that the inflammatory changes were more frequent and severe in group II than in group I. Mast-cell hyperplasia was present in 100% of the patients in group II, versus only 61% of those in group I. A total of 23 patients (92%) achieved an initial remission averaging 8.1 months. In all, 9 patients (35%) had 1 or more relapses, and all achieved a subsequent remission averaging 8 months. By this combined multiagent approach, the majority of patients with IC obtained relief from their incapacitating symptoms and were socially rehabilitated.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Campbell A, Converse PE, Rodgers WL (1976) The quality of American life; perception, evaluations and satisfactions. Russell Sage Foundation, New York, pp 528–556
Oravisto KJ (1975) Epidemiology of interstitial cystistis. Ann Chir Gynaecol 172:75–77
Hunner GL (1915) A rare type of bladder ulcer in women: report of cases. Boston Med Surg J 172:660–664
Hanash KA, Pool TL (1970) Interstitial and hemorrhagic cystitis: viral, bacterial and fungal studies. J Urol 104:705–706
Clemmensen O, Lose G, Holm-Bentzen M, Colstrup H (1988) Skin reactions to urine in patients with interstitial cytitis. Urology 32:17–20
Oravisto KJ, Alfthan OS, Jokinen EJ (1970) Interstitial cystitis, clinical and immunological findings. Scand J Urol Nephrol 4:37–42
Silk MR (1970) Bladder antibodies in interstitial cystistis. J Urol 103:397–309
Bohne AW, Hodson JM, Rebuck JW, Reinhard RE (1962) An abnormal leukocyte response in interstitial cystitis. J Urol 88:387–391
Jokinen EJ, Alfthan Os, Oravisto KJ (1972) Antitissue antibodies in interstitial cystitis. Clin Exp Immunol 11:333–339
Phillips JI (1981) Inflammatory plasma cell infiltration of the urinary bladder in the aging C57BL lerfa mouse. Invest Urol 19:75–78
Mattila J, Harmoinen A, Hallstrom O (1983) Serum immunoglobulin and complement alterations in interstitial cystitis. Eur Urol 9:350–352
Hellstrom HR, Davis BK, Shonnard JW (1979) Eosinophilic cystitis, a study of 16 cases. Am J Clin Pathol 72:777–784
McGuire EJ, Lytton B, Cornog JL (1973) Interstitial cystitis following colocystoplasty. Urology 2:28–29
Mattila J (1982) Vascular immunopathology in interstitial cystitis. Clin Immunol Immunopathol 23:648–655
Mattila J, Pitkanen R, Vaalasti T, Seppanen J (1983) Fine-structural evidence for vascular injury in patients with interstitial cystitis. Virchows Arch 398:347–355
Larsen S, Thompson SA, Hald T, Barnard RJ, Giplin CJ, Dixon JS, Gosling JA (1982) Mast cells in interstitial cystitis. Br J Urol 54:283–286
Dixon JS, Hald T (1986) Morphological studies of the bladder wall in interstitital cystitis. In: George NJR, Gosling JA (eds) Sensory disorders of the bladder and urethra. Springer, Berlin Heidelberg New York, pp 63–70
Simmons JL, Bunce PL (1958) On the use of an antihistamine in the treatment of interstitial cystitis. Am Surg 24:664
Clark IM (1981) Amitriptyline and perphenazine (Triptafeln, DA) in chronic pain. Anesthesia 36:210–212
Duthie AM (1971) The use of phenothiazines and tricyclic antidepressants in the treatment of intractable pain: S Afr Med J 51:246–247
Parsons CL, Stauffer C, Schmidt JD (1980) Bladder-surfac glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 208:605
Parsons CL, Schmidt JD, Pollen JJ (1983) Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol 130:51–53
Sant GR, Ucci AA, Alroy J (1986) Bladder surface glycosaminoglycans in interstitial cystitis. J Urol 135:175A
Lose G, Frandsen B, Hojensgard JC, Jespersan J, Astrup T (1983) Chronic interstitial cystitis. Increased levels of eosinophil cationic protein in serum and urine and an ameliorating effect of subcutaneous heparin. Scand J Urol Nephrol 17:159–161
Lose G, Jepersen J, Frandsen B, Hojensgrad JC, Astrup T (1985) Subcutaneous heparin in the treatment of interstitial cystitis. Scand J Urol Nephrol 19:27–29
Hirsch LB, Montella JM, Bent AE (1991) Detrusor instability. In: Ostergard DR, Bent AE (eds) Urogynecology and urodynamics theory and practice, 3rd edn. Williams and Wilkins, Baltimore, pp 363–367
Stewart BH, Shirley SW (1976) Further experience with intravesical dimethyl sulfoxide in treatment of interstitial cystitis. J Urol 116:36–38
Fowler JE JR (1981) Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis. Urology 18:21–26
Worth PHL, Turner-Warwick R (1973) The treatment of interstitial cystitis by cystolysis with observations on cystoplasty. Br J Urol 45:65–71
Weiss JP, Wein AJ, Hanno PM (1984) Sigmoidocystoplasty to augment bladder capacity. Surg Gynecol Obstat 159:377–380
Seddon JM, Best L, Bruce AW (1977) Intestinocystoplasty in treatment of interstitial cystitis. Urology 10:431–435
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghoniem, G.M., McBride, D., Sood, O.P. et al. Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy. World J Urol 11, 178–182 (1993). https://doi.org/10.1007/BF00211416
Issue Date:
DOI: https://doi.org/10.1007/BF00211416